Home › All Companies › AVXL › Insider Trading

ANAVEX LIFE SCIENCES CORP. (AVXL) — Insider Trading

AI-Powered SEC Filing Analysis

← All AVXL filings
Latest Insider Trading Filed: 2026-01-09

Key Insights

  • The reporting person, Sandra Boenisch, who is the PFO and Treasurer of Anavex Life Sciences Corp., acquired 12,500 stock options on January 6, 2026 at an exercise price of $8.58 per share.
  • The stock options were granted on March 31, 2025 and vest based on the achievement of certain performance milestones, one of which was a second regulatory dialogue for the company's drug candidate blarcamesine.
  • The vesting of 12,500 options indicates the company has achieved the performance milestone related to the regulatory dialogue for blarcamesine, which is a positive development for the company's pipeline.
Sentiment: Positive Significance: 6/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-01-09. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-01-09
  • The reporting person, Christopher Missling, who is the President and CEO of Anavex Life Sciences Corp. (AVXL), has been granted an option to purchase 500,000 shares of the company's common stock, with 125,000 shares vesting due to the achievement of a performance milestone.
  • The option grant and vesting event indicate the company's confidence in the leadership and commitment of the CEO, which could be positive for investor sentiment.
  • Investors should monitor any future insider trading activity by the CEO, as it may provide insight into the company's prospects and the CEO's outlook on the stock.
Sentiment: Positive Significance: 7/10
View Original Filing →

Other reports for ANAVEX LIFE SCIENCES CORP.

Current Report Quarterly Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.